TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial.

Lisanne A H Bevers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.